Amber Theraputics Brand Mark BURNT ORANGE.png
Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
February 27, 2024 09:00 ET | Amber Therapeutics
Key initial results from AURA-2 study highlight good safety and scalability of Amber-UI therapy A strong efficacy signal was seen in the form of complete resolution of incontinence episodes six months...
MnM_logo_TM_JPG.JPG
Neuromodulation Market is Expected to Reach $11.0 Billion | MarketsandMarkets™
February 22, 2024 07:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Neuromodulation market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at a CAGR...
22157.jpg
Neuromodulation Devices Market Report 2024-2034: Surging Demand for Deep Brain Stimulation (DBS) in Neuromodulation
February 12, 2024 04:37 ET | Research and Markets
Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "Neuromodulation Devices Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.Revenue for the neuromodulation devices market is...
FDA Clears Magstim TMS Horizon 3.0 with StimGuide Pro Treatment for Patients with Depression, Obsessive Compulsive Disorder, Anxious Depression
FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro
January 30, 2024 09:18 ET | Magstim EGI
FDA clears Magstim TMS System Horizon 3.0 with StimGuide Pro providing treatment for patients patients with depressive or obsessive-compulsive conditions
Curonix-PrimaryLogo_CMYK.png
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
January 18, 2024 08:00 ET | Curonix LLC
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
22157.jpg
Global Neuromodulation Devices Markets, 2021-2027 with 2023 as the Base Year - Future Growth Potential Enhanced by Expanding Clinical Indications and Technological Advancements
October 13, 2023 06:13 ET | Research and Markets
Dublin, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Neuromodulation Devices Market, Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.This research service analyzes the...
22157.jpg
Global Neuromodulation Strategic Research Report 2023: Market to Reach $11.6 Billion by 2030 - Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
September 29, 2023 04:13 ET | Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Neuromodulation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Neuromodulation Market to Reach...
Final Logo-01.png
Neuromodulation Market is estimated to be US$ 12.23 billion by 2030 with a CAGR of 8.9% during the forecast period – By PMI
September 28, 2023 13:00 ET | PMI
Covina, Sept. 28, 2023 (GLOBE NEWSWIRE) -- What is Neuromodulation? Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of...
Synapse Dental Completes Equity Financing Round with Backing From AAO Innovation & Transformation Fund
September 22, 2023 08:00 ET | Synapse Dental
CRANSTON, R.I., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Synapse Dental, the maker of the Dental Pain EraserTM, announced the completion of its first outside equity financing with backing from the...
URIS Neuromodulation System
STIMVIA Unveils Innovative Solution to Transform CNS Disorder Treatments at TechCrunch Disrupt 2023
September 20, 2023 12:00 ET | STIMVIA s.r.o.
SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- STIMVIA, a pioneer medical technology company, introduces an effective non-invasive neuromodulation treatment, URIS®, addressing deep brain...